3[1]Flens MJ,Zaman GJR,Valk PVD,et al. Tissue distribution of the multidrug resistance protein[J]. Am J Pathel,1996,148(4): 1237.
4[2]Loe DW,Deeley RG,Cole SPC. Biology of the multidrug resistance-associated protein MRP [J]. Euro J Cancer,1996,32(6) :945.
5[3]Lautier D, Canitor Y, Deeley RG, et al. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene[J ]. Biochem Pharm, 1996,52(7) :967.
6[4]Izquierdo MA,Scheffer GL,Flens MJ,et al. Broad distribution of multidrug resistance-related vault lung resistance protein in normal tissues and tumors [J ]. Am J Pathol,1996,148(3) :877.
7[5]Izquierdo MA, Scheffer GL, Flens MJ,et al. Major vault protein LRP-related multidrug resistance[J ]. Euro J Cancer, 1996,32: 979.
8[6]Chugani DC, Rome LH, Kedersha NL . Evidence that vault ribonucleoprotein particles locatize to the nuclear pore complex[J ]. J cell Sci, 1993,106(Pt1) :23.
9[7]Kitazono M, Sumizawa T, Takebayashi Y,et al. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-120 cells[J]. J Natl Cancer Inst, 1999,91(19) : 1647.
10Fujji H, Tanigawa N, Muraoka R, et al. Clinical significance of multi-drug resistance and P-glycoprotein expression in patients with gastric carcinoma. J Surg Oncol, 1995,58 : 63.
